You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 7, July 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders, Other
 •Alert me on articles by topic

Sweet Syndrome

A Disease in Histologic Evolution?

Arch Dermatol. 2005;141:893-895.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Sweet syndrome (SS) occurs in several predictable clinical settings: those with inflammatory conditions, perhaps most commonly following upper respiratory tract infection; those with hematologic dyscrasias and malignancies, most commonly involving cells of myeloid lineage; and in a variety of other settings. Sweet syndrome occurring in the setting of myeloid malignancy may histologically and clinically appear atypical for a number of reasons: clinically, some of these lesions appear purpuric owing to associated thrombocytopenia; SS occurring as a manifestation of myeloid dyscrasia does not exhibit a predominance in women, unlike the other forms of the disease; and histologically, some of these cases exhibit mononuclear cells compatible with leukemic granulocytic precursors combined with mature neutrophils.1

Histopathologically, SS is less predictable. The histologic characteristics of this neutrophil-predominant dermatosis have been considered fairly uniform but have been called into question in the literature recently. There has been much controversy regarding the presence of fibrinoid degeneration . . . [Full Text of this Article]


AUTHOR INFORMATION
Janine C. Malone, MD; Stephen P. Slone, MD


RELATED ARTICLES

Histiocytoid Sweet Syndrome: A Dermal Infiltration of Immature Neutrophilic Granulocytes
Luis Requena, Heinz Kutzner, Gabriele Palmedo, Marta Pascual, Jesús Fernández-Herrera, Javier Fraga, Amaro García-Díez, and Evaristo Sánchez Yus
Arch Dermatol. 2005;141(7):834-842.
ABSTRACT | FULL TEXT  

Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis) Associated With Pulmonary Coccidioidomycosis
David J. DiCaudo, Karel Jill Ortiz, Stephanie J. Mengden, and Katherine K. Lim
Arch Dermatol. 2005;141(7):881-884.
ABSTRACT | FULL TEXT  

A Case of Sweet Syndrome Associated With Human Granulocytic Anaplasmosis
Charles L. G. Halasz, G. William Niedt, Caroline P. Kurtz, Diana G. Scorpio, Johan S. Bakken, and J. Stephen Dumler
Arch Dermatol. 2005;141(7):887-889.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Histologic Pitfall in Sweet Syndrome
Journal Watch Dermatology 2005;2005:1-1.
FULL TEXT  

Medical Dermatology Is Alive and Well
Callen and Robinson
Arch Dermatol 2005;141:825-826.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.